


Healthcare News Roundup: Personne
HSMN NewsFeed - 6 May 2019
Fresenius Medical Care North America Announces Leadership Additions Following NxStage Merger
Fresenius Medical Care North America Announces Leadership Additions Following NxStage Merger
HSMN NewsFeed - 6 May 2019
Halozyme Names Dr. Alison A. Armour As Senior Vice President of Research and Development
Halozyme Names Dr. Alison A. Armour As Senior Vice President of Research and Development
HSMN NewsFeed - 1 May 2019
Athira Pharma Announces Appointment of Dr. Hans J. Moebius as Chief Medical Officer
Athira Pharma Announces Appointment of Dr. Hans J. Moebius as Chief Medical Officer
HSMN NewsFeed - 30 Apr 2019
Vividion Therapeutics Announces Oversubscribed $82 Million Series B Financing
Vividion Therapeutics Announces Oversubscribed $82 Million Series B Financing
HSMN NewsFeed - 24 Apr 2019
OncoSec Appoints Industry Veteran Margaret R. Dalesandro, Ph.D., to its Board of Directors
OncoSec Appoints Industry Veteran Margaret R. Dalesandro, Ph.D., to its Board of Directors
HSMN NewsFeed - 23 Apr 2019
Akero Therapeutics Appoints Industry Veteran Jane Pritchett Henderson to Board of Directors
Akero Therapeutics Appoints Industry Veteran Jane Pritchett Henderson to Board of Directors
HSMN NewsFeed - 22 Apr 2019
Epic Sciences Appoints Richard J. Wenstrup, M.D. as Chief Medical Officer
Epic Sciences Appoints Richard J. Wenstrup, M.D. as Chief Medical Officer
HSMN NewsFeed - 16 Apr 2019
Cerebral Therapeutics Strengthens Clinical Development Leadership with Strategic Appointments
Cerebral Therapeutics Strengthens Clinical Development Leadership with Strategic Appointments
HSMN NewsFeed - 16 Apr 2019
Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors
Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors
HSMN NewsFeed - 10 Apr 2019
Rapid Dose Therapeutics Appoints Chief Financial Officer and Provides Business Update
Rapid Dose Therapeutics Appoints Chief Financial Officer and Provides Business Update
HSMN NewsFeed - 10 Apr 2019
Phio Pharmaceuticals Appoints Dr. John Barrett as Chief Development Officer
Phio Pharmaceuticals Appoints Dr. John Barrett as Chief Development Officer
HSMN NewsFeed - 9 Apr 2019
Orgentec Diagnostika Appoints Global Healthcare Leader Gary Winer As President And CEO
Orgentec Diagnostika Appoints Global Healthcare Leader Gary Winer As President And CEO
HSMN NewsFeed - 2 Apr 2019
Petra Pharma Strengthens Management Team with Recent Leadership Appointments
Petra Pharma Strengthens Management Team with Recent Leadership Appointments
HSMN NewsFeed - 1 Apr 2019
Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer
Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer
HSMN NewsFeed - 29 Mar 2019
Allogeneic CAR-T Specialists TC BioPharm Appoint Prof John Anderson as Scientific and Medical Director
Allogeneic CAR-T Specialists TC BioPharm Appoint Prof John Anderson as Scientific and Medical Director
HSMN NewsFeed - 28 Mar 2019
Hyalex Orthopaedics, synthetic cartilage company, adds new funding; expanding Series A total to $33MM
Hyalex Orthopaedics, synthetic cartilage company, adds new funding; expanding Series A total to $33MM
HSMN NewsFeed - 28 Mar 2019
Brian Pilcher, PhD Appointed as Chief Scientific Officer at Suneva Medical
Brian Pilcher, PhD Appointed as Chief Scientific Officer at Suneva Medical
HSMN NewsFeed - 27 Mar 2019
Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer
Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer
HSMN NewsFeed - 19 Mar 2019
Centinel Spine Appoints Dirk M. Kuyper and Gregory Rainey to its Board of Directors
Centinel Spine Appoints Dirk M. Kuyper and Gregory Rainey to its Board of Directors
HSMN NewsFeed - 18 Mar 2019
Cantel Appoints Jean Casner to Senior Vice President and Chief Human Resources Officer
Cantel Appoints Jean Casner to Senior Vice President and Chief Human Resources Officer
HSMN NewsFeed - 18 Mar 2019
Bryan Reasons Joins Mallinckrodt as the Company's Chief Financial Officer (CFO)
Bryan Reasons Joins Mallinckrodt as the Company's Chief Financial Officer (CFO)
